Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha subunit in gestational trophoblastic disease.

E I Kohorn, B V Caldwell, J M Cortes

    Placenta. Supplement
    |January 1, 1981
    PubMed
    Summary

    Alpha HCG monitoring is not valuable for low-risk gestational disease patients, as its levels mirror beta-HCG. Further research is needed to determine if elevated Alpha HCG predicts recurrence in high-risk metastatic cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Do imaging techniques, grey scale ultrasound, color doppler flow ultrasound and magnetic resonance imaging provide clinically useful information during the therapy of nonmetastatic gestational trophoblastic neoplasia.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Ising model with conserved magnetization on the human connectome: Implications on the relation structure-function in wakefulness and anesthesia.

    Chaos (Woodbury, N.Y.)·2017
    Same author

    Synergy, redundancy and unnormalized Granger causality.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2016
    Same author

    Development of an analytical method for the determination of the misuse in sports of boldenone through the analysis of urine by on-line coupling liquid chromatography-gas chromatography-combustion-isotope ratio mass spectrometry.

    Journal of chromatography. A·2014
    Same author

    Neoplasm transplantation inhibition by uninvolved lymph tissue.

    Nature·2010
    Same author

    Dynamics and robustness of familiarity memory.

    Neural computation·2009

    Area of Science:

    • Reproductive Endocrinology
    • Gynecologic Oncology

    Background:

    • Human Chorionic Gonadotropin (HCG) is a key biomarker in gestational trophoblastic disease.
    • Monitoring HCG levels, specifically the beta-subunit (beta-HCG), is crucial for treatment assessment.
    • The role of the alpha-subunit (alpha-HCG) in monitoring disease progression requires further clarification.

    Purpose of the Study:

    • To evaluate the clinical utility of monitoring alpha-HCG levels post-hydatidiform mole evacuation.
    • To compare the trends of alpha-HCG and beta-HCG in patients with gestational disease.
    • To determine if alpha-HCG provides additional prognostic value beyond beta-HCG.

    Main Methods:

    • Retrospective analysis of alpha-HCG and beta-HCG levels in patients after hydatidiform mole evacuation.
    • Comparison of HCG subunit kinetics in low-risk non-metastatic gestational disease.
    • Assessment of alpha-HCG trends in relation to beta-HCG levels during remission and potential recurrence.

    Main Results:

    • Alpha-HCG levels were found to parallel the decline of beta-HCG in patients post-hydatidiform mole evacuation.
    • In low-risk non-metastatic gestational disease, alpha-HCG values mirrored beta-HCG trends, suggesting no added benefit.
    • The study could not resolve whether alpha-HCG elevation predicts recurrence in high-risk metastatic cases in remission.

    Conclusions:

    • Monitoring alpha-HCG offers no additional value for low-risk non-metastatic gestational disease patients.
    • The prognostic significance of alpha-HCG in high-risk metastatic gestational disease requires further investigation.
    • Current findings suggest focusing on beta-HCG for routine monitoring in most gestational trophoblastic disease cases.

    Related Experiment Videos